| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.35▲ | 4.35▲ | 4.35▲ | 4.37▼ | 4.23▲ |
| MA10 | 4.24▲ | 4.25▲ | 4.25▲ | 4.32▼ | 4.40▼ |
| MA20 | 4.52▼ | 4.55▼ | 4.53▼ | 4.21▲ | 4.39▼ |
| MA50 | 4.44▼ | 4.41▼ | 4.37▲ | 4.50▼ | 4.07▲ |
| MA100 | 4.24▲ | 4.18▲ | 4.17▲ | 4.41▼ | 4.71▼ |
| MA200 | 4.82▼ | 4.90▼ | 4.99▼ | 4.11▲ | 5.15▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.010▼ | -0.023▼ | -0.022▼ | 0.033▲ | -0.041▼ |
| RSI | 48.768▼ | 48.933▼ | 49.337▼ | 48.426▼ | 49.634▼ |
| STOCH | 47.903 | 47.903 | 47.903 | 61.485 | 26.854 |
| WILL %R | -63.542 | -63.542 | -63.542 | -47.170 | -65.455 |
| CCI | 27.913 | 6.524 | 6.524 | -3.315 | -41.059 |
|
Sunday, April 19, 2026 10:03 AM
MP0632 nominated as first logic-gated Switch-DARPin T cell engager candidate for the treatment of MSLN/EpCAM expressing solid tumors, with preclinical data indicating favorable therapeutic ...
|
|
Tuesday, April 14, 2026 01:00 PM
LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the ...
|
|
Monday, March 23, 2026 02:00 AM
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 23, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/04/26 | 4.28 | 4.28 | 4.28 | 4.28 | 830 |
| 27/04/26 | 4.35 | 4.35 | 4.35 | 4.35 | 1,689 |
| 24/04/26 | 4.47 | 4.47 | 4.4599 | 4.4599 | 1,061 |
| 23/04/26 | 4.40 | 4.47 | 4.40 | 4.40 | 2,170 |
| 22/04/26 | 4.3401 | 4.3401 | 4.3401 | 4.3401 | 1,286 |
| 21/04/26 | 4.42 | 4.42 | 4.35 | 4.35 | 909 |
| 20/04/26 | 4.37 | 4.53 | 4.2576 | 4.41 | 6,730 |
| 17/04/26 | 4.18 | 4.205 | 4.18 | 4.205 | 2,748 |
| 16/04/26 | 4.18 | 4.18 | 4.18 | 4.18 | 2,066 |
| 15/04/26 | 4.15 | 4.20 | 4.15 | 4.20 | 1,088 |
|
|
||||
|
|
||||
|
|